edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
In this interview, Dr David Ebsworth, non-executive chairman of Verona Pharma, provides an overview of the company and its pipeline of assets. He goes on to discuss plans for the pivotal Phase III development of ensifentrine, the company’s lead product, as well as the regulatory and commercial strategy in Verona Pharma’s core markets. He finishes the interview by explaining how the company is funded and upcoming catalysts investors should pay attention to.
Get access to the very latest content matched to your personal investment style.